Pharmaceutical Supply, Pharmaceutical Manufacturing, Contract …
WEBPharmaceutical Supply, Pharmaceutical Manufacturing, Contract Research, Pharmaceutical Outsourcing. News and analysis on clinical trial services and contract research and development. Pfizer withdraws sickle cell disease drug Oxbryta amid safety concerns. The US big pharma company Pfizer has voluntarily withdrawn the oral sickle cell disease ...
Niche providers vs full-service CROs
WEBDec 5, 2006 · According to Ylisaari, the main advantage of niche providers is that they are usually experts in their field, whereas big companies may have some areas that they. Smaller providers also tend to be more flexible, she said. Adding to this, Lipscombe said that smaller CROs are often associated with a high …
About us - outsourcing-pharma.com
WEBAbout us. , the specialist B2B media, business intelligence and events group dedicated to helping businesses succeed. Our diverse portfolio of category-leading brands serves a global audience of almost 5M monthly users, supported by sector-specific insights & research, up-to-the-minute digital media and cutting-edge customer solutions.
$680M deal with CBC and Mubadala shifts UCB's strategy
WEBAug 29, 2024 · The $680 million transaction, announced on August 26, involves the sale of established brands such as Keppra, Vimpat, Neupro, Zyrtec, and Xyzal, along with UCB's Zhuhai manufacturing site, to CBC Group and Mubadala Investment Company. This deal marks a pivotal moment in UCB’s evolution, as the company shifts its focus towards innovation and ...
Excipients, raw materials & intermediates
WEBThe raw material supply is too vital to leave to chance, and quality-related supply chain activities are cornerstones to your success. Continuous Manufacturing Technology continues to gain importance in pharmaceutical manufacturing. Formulation of bi-layer or multi-layer tablets enables the combination of two or more drugs that may be ...
CorePharma to reopen under new ownership following Impax sale
WEBJan 31, 2018 · Impax Laboratories, Inc. acquired Tower Holdings, Inc, which included operating subsidiaries CorePharma LLC and Amedra Pharmaceuticals LLC, in March 2015. CorePharma’s Middlesex, NJ-based headquarters feature two manufacturing and packaging facilities totaling approximately 60,000 square feet. Both facilities are FDA and DEA registered and ...
Blood-based Alzheimer’s test set to revolutionize early diagnosis
WEBAug 27, 2024 · This antibody is integral to advanced blood-based tests that are transforming Alzheimer’s diagnosis, treatment, and real-time disease monitoring. Our collaboration with Beckman Coulter aims to democratize access to the pTau217 antibody, developing it into a highly accurate blood-based test on the DxI 9000 analyzer.
SANOFI - CEPiA
WEBCEPiA (Commercial & External Partnership, Industrial Affairs) is an organization fully dedicated to third party activities within the Industrial Affairs of Sanofi.One of the key activities of CEPiA is to offer a broad range of innovative solutions including:Supply of Active Pharmaceutical Ingredients (APIs) and IntermediatesCustom Synthesis & API Contract ManufacturingPharma Contract ...
Lonza expands manufacturing with bottling and labeling at US site
WEBAug 15, 2024 · Lonza boosts clinical services with new bottling capabilities. Lonza, a global leader in the pharmaceutical, biotech, and nutraceutical markets, has announced a significant expansion of its clinical manufacturing services at its small molecules site in Bend, Oregon. The upgrade includes the installation of advanced bottling and labeling ...
Melanie Adams-Cioaba on leading the cryo-EM revolution in drug …
WEBAug 22, 2024 · In the rapidly evolving field of drug discovery, Melanie Adams-Cioaba stands at the forefront, leading transformative advancements in cryo-electron microscopy (cryo-EM) at Thermo Fisher Scientific. As the senior director and general manager of pharma (Cryo-EM), Melanie is not only pioneering the use …